Literature DB >> 1713030

Virus-neutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens.

K J Fahey1, P McWaters, M A Brown, K Erny, V J Murphy, D R Hewish.   

Abstract

Murine monoclonal antibodies (MAbs) were produced to assist in the identification and characterization of the virus-neutralizing epitopes of infectious bursal disease virus (IBDV). Only MAbs that reacted in Western blotting with viral protein 2 (VP2) or immunoprecipitated VP2 neutralized the infectivity of the virus in cell culture and passively protected young chickens from infection. Three of the neutralizing MAbs did not react with denatured viral proteins. Additivity enzyme-linked immunosorbent assays indicated that the six virus-neutralizing MAbs recognized two spatially independent epitopes. The ability of two of the virus-neutralizing MAbs to neutralize a variant of IBDV that had escaped neutralization by all the other MAbs confirmed the existence of two distinct neutralizing epitopes. The results support the hypothesis that there are at least two non-overlapping epitopes recognized by the virus-neutralizing MAbs reported in this study, although these may still be within one conformational site on VP2 of IBDV.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713030

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  10 in total

1.  Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States.

Authors:  D B Snyder; V N Vakharia; P K Savage
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.

Authors:  K Tsukamoto; S Saito; S Saeki; T Sato; N Tanimura; T Isobe; M Mase; T Imada; N Yuasa; S Yamaguchi
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Adaptation of very virulent infectious bursal disease virus to chicken embryonic fibroblasts by site-directed mutagenesis of residues 279 and 284 of viral coat protein VP2.

Authors:  B L Lim; Y Cao; T Yu; C W Mo
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  The working mechanism of an immune complex vaccine that protects chickens against infectious bursal disease.

Authors:  S H Jeurissen; E M Janse; P R Lehrbach; E E Haddad; A Avakian; C E Whitfill
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

5.  Biological roles of the major capsid proteins and relationships between the two existing serotypes of infectious bursal disease virus.

Authors:  S K Reddy; A Silim; M J Ratcliffe
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

6.  Epitope mapping of capsid proteins VP2 and VP3 of infectious bursal disease virus.

Authors:  T Yamaguchi; K Iwata; M Kobayashi; M Ogawa; H Fukushi; K Hirai
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens.

Authors:  H G Heine; D B Boyle
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  Evaluation of VP2 epitopes of infectious bursal disease virus using in vitro expression and radioimmunoprecipitation.

Authors:  J M Crisman; R J Jackwood; D P Lana; D J Jackwood
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit.

Authors:  Marina Arnold; Vijay Durairaj; Egbert Mundt; Katja Schulze; Karin D Breunig; Sven-Erik Behrens
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

Review 10.  Recent advances in avian virology.

Authors:  D Cavanagh
Journal:  Br Vet J       Date:  1992 May-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.